Trial Search Results

Symptom Screening Linked to Care Pathways

Most children with cancer survive because they are given intensive treatments, but unfortunately, these treatments are associated with distressing symptoms. To address this problem, we developed the Symptom Screening in Pediatrics Tool (SSPedi) so that children receiving cancer treatments can communicate their bothersome symptoms, and Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a web-based application that links identified symptoms to supportive care guidelines for symptom management. To establish that these tools improve the lives of children newly diagnosed with cancer, we will conduct a trial that randomizes 20 pediatric cancer institutions and measures the impact of three times weekly symptom screening, symptom feedback to healthcare providers and the development of care pathways for symptom management to improve total symptom burden, fatigue and quality of life.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

The Hospital for Sick Children

Collaborator: National Cancer Institute (NCI)

Stanford Investigator(s):


  • Behavioral: SPARK Symptom Screening Linked to Feedback to Providers


Phase 3


Inclusion Criteria:

   - 8-18 years of age at enrollment

   - English or Spanish-speaking

   - Any newly diagnosed cancer

   - Have a plan for any chemotherapy, radiotherapy or surgery

   - Enroll within 28 days after treatment initiation

Exclusion Criteria:

   - Cognitive disability (attending minimum second grade or equivalent)

   - Visual impairment (cannot see SPARK even with corrective lens)

Ages Eligible for Study

8 Years - 18 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Christina (Tina) R Baggott